EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dose Accuracy and Reliability of a Connected Insulin Pen System

Matthew Backfish, Kimberly Kovalchick, Robert Albert, Myriam Rosilio iD, Farai Chigutsa, Birong Liao

Journal of Diabetes Science and Technology · 2026

DOI: 10.1177/19322968241301760 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Science and Technology, 2026. Verfasst von Matthew Backfish und 5 weiteren Autor:innen. Beteiligte Einrichtung: Eli Lilly and Company, Indianapolis, IN, USA. Hauptthemen laut MEDLINE: Insulin, Hypoglycemic Agents, Diabetes Mellitus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Eli Lilly and Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For people with diabetes on insulin injection therapy, insulin pen dose accuracy and reliability are key features. Dose accuracy of the Tempo Pen TM with attached Tempo Smart Button TM [Module] (the system) was tested for three doses under standard atmospheric conditions. Reliability and the ability of the Module to detect, store, and transmit dose-related data were also tested. The system met the International Organization for Standardization 11608-1:2014 requirements for dose accuracy at all doses. Mean (standard deviation) doses were 0.010 mL (0.002), 0.299 mL (0.002), and 0.597 mL (0.004) for the 0.010-mL, 0.300-mL, and 0.600-mL doses, respectively. The Module also met requirements for data transfer after every injection. The system accurately delivered doses and reliably captured and stored insulin dosing information.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinHypoglycemic AgentsDiabetes MellitusHumansReproducibility of ResultsInjections, SubcutaneousInsulin Infusion Systems

Stichwörter der Autor:innen

Tempo PenTempo Smart Buttonconnected insulin penself-management

Substanzen

InsulinHypoglycemic Agents

Autor:innen und Institutionen

  • Eli Lilly and Company, Indianapolis, IN, USA.

ORCID-Profile: Myriam Rosilio

Förderung

  • Eli Lilly and Company

Zitieren

APA

Backfish, M., Kovalchick, K., Albert, R., Rosilio, M., Chigutsa, F., & Liao, B. (2026). Dose Accuracy and Reliability of a Connected Insulin Pen System. Journal of Diabetes Science and Technology. https://doi.org/10.1177/19322968241301760

Vancouver

Backfish M, Kovalchick K, Albert R, Rosilio M, Chigutsa F, Liao B. Dose Accuracy and Reliability of a Connected Insulin Pen System. Journal of Diabetes Science and Technology. 2026. doi:10.1177/19322968241301760

BibTeX
@article{Backfish2026,
  author = {Backfish, Matthew and Kovalchick, Kimberly and Albert, Robert and Rosilio, Myriam and Chigutsa, Farai and Liao, Birong},
  title = {Dose Accuracy and Reliability of a Connected Insulin Pen System},
  journal = {Journal of Diabetes Science and Technology},
  year = {2026},
  doi = {10.1177/19322968241301760}
}
Kostenlos starten →